Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis

Hepatology

Volumn 61, Issue 3, 2015, Pages 870-882

  Wang, Chao ^a,b   Zhao, Yuanlin ^a   Gao, Xing ^a   Li, Le ^a   Yuan, Yuan ^a   Liu, Fang ^c   Zhang, Lijun ^b   Wu, Jie ^a   Hu, Peizhen ^a   Zhang, Xiumin ^a   Gu, Yu ^a   Xu, Yuqiao ^a   Wang, Zhe ^a   Li, Zengshan ^a   Zhang, Huizhong ^b   Ye, Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Xi'an Satellite Measuring and Control Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TRIGLYCERIDE LIPASE; FATTY ACID; PERILIPIN; PERILIPIN 5; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; LIPID STORAGE DROPLET PROTEIN 5, MOUSE; MUSCLE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SIGNAL PEPTIDE;

ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; HEPATIC LIPOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIPOLYSIS; LIPOTOXICITY; LIVER CELL; LIVER TOXICITY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; ANIMAL; CELL PROLIFERATION; CHEMISTRY; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; LIPID METABOLISM; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; LIPOLYSIS; LIVER; MICE; MUSCLE PROTEINS; PPAR ALPHA; PROTEIN STRUCTURE, TERTIARY;

EID: 84923489646     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27409     Document Type: Article

References (30)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-S112.
2. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48(Suppl 1):S104-112.
3. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012;142:711-725 e716.
4. Gaemers IC, Stallen JM, Kunne C, Wallner C, van Werven J, Nederveen A, et al. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. Biochim Biophys Acta 2011;1812:447-458.
5. Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 2005;10:3093-3099.
6. Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr 2011;53:131-140.
7. Dalen KT, Dahl T, Holter E, Arntsen B, Londos C, Sztalryd C, et al. LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues. Biochim Biophys Acta 2007;1771:210-227.
8. Granneman JG, Moore HP, Mottillo EP, Zhu Z, Zhou L. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase. J Biol Chem 2011;286:5126-5135.
9. Granneman JG, Moore HP, Mottillo EP, Zhu Z. Functional interactions between Mldp (LSDP5) and Abhd5 in the control of intracellular lipid accumulation. J Biol Chem 2009;284:3049-3057.
10. Wang H, Bell M, Sreenivasan U, Hu H, Liu J, Dalen K, et al. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem 2011;286:15707-15715.
11. Kimmel AR, Sztalryd C. Perilipin 5, a lipid droplet protein adapted to mitochondrial energy utilization. Curr Opin Lipidol 2014;25:110-117.
12. Wang H, Sreenivasan U, Hu H, Saladino A, Polster BM, Lund LM, et al. Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria. J Lipid Res 2011;52:2159-2168.
13. Wang H, Sztalryd C. Oxidative tissue: perilipin 5 links storage with the furnace. Trends Endocrinol Metab 2011;22:197-203.
14. Kuramoto K, Okamura T, Yamaguchi T, Nakamura TY, Wakabayashi S, Morinaga H, et al. Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation. J Biol Chem 2012;287:23852-23863.
15. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006;87:1-16.
16. Zambo V, Simon-Szabo L, Szelenyi P, Kereszturi E, Banhegyi G, Csala M. Lipotoxicity in the liver. World J Hepatol 2013;5:550-557.
17. Pagliassotti MJ. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu Rev Nutr 2012;32:17-33.
18. Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 2012;15:623-634.
19. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem 2004;279:35150-35158.
20. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 2008;118:2808-2821.
21. Widlansky ME, Gutterman DD. Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal 2011;15:1517-1530.
22. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 1996;12:335-363.
23. Hostetler HA, McIntosh AL, Atshaves BP, Storey SM, Payne HR, Kier AB, et al. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes. J Lipid Res 2009;50:1663-1675.
24. Brasaemle DL. Perilipin 5: putting the brakes on lipolysis. J Lipid Res 2013;54:876-877.
25. Li H, Song Y, Zhang LJ, Gu Y, Li FF, Pan SY, et al. LSDP5 enhances triglyceride storage in hepatocytes by influencing lipolysis and fatty acid beta-oxidation of lipid droplets. PLoS One 2012;7:e36712.
26. Bickel PE, Tansey JT, Welte MA. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta 2009;1791:419-440.
27. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003;14:281-287.
28. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004;53:1412-1417.
29. Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012;15:279-291.
30. Dong H, Czaja MJ. Regulation of lipid droplets by autophagy. Trends Endocrinol Metab 2011;22:234-240.